Ekonomi Haberleri

İçinde ('Altın ','USD ','Dolar ','EURO ','AVRO ','Faiz ','Gold ','Lira ','TRY ','USD ','Dollar ','cripto','crypto','Baş ','Chief ','Finance ','Finans ','Gayrimenkul','Kripto ','Küresel ') ve ('FED ','Stock ','NYSE ','S-400 ','F-35 ','Fitch ','S&P ','Moody's','Borsa ','IMKB ','Petrol ','Oil ','Merkez ','para ','money ','companies','company','Economist ','Ekonomist ','currencies','currency','Economy','Ekonomi','Economies','yatırım','Piyasa') ve ('ABD ',' US ',' EU ','Turkey','Turkish','Russia','China','Türkiye') kelime gruplarından en az 2 sinin içindeki kelimelerden birinin aynı anda geçtiği haberler.

Ekleyen: İnternet Robotu
Haber: Haber Kaynağı: Çeşitli Haber Siteleri
STAT+: Pharmalittle: FTC’s top economist quits amid PBM-study spat; FDA clinical holds have become more common
Many analysts say the Biden administration’s efforts to boost the power of consumers at the expense of the pharmaceutical industry have had only mixed success.
https://www.statnews.com/pharmalot/2022/02/28/covid19-vaccine-fda-ftc-pbm-glaxo-biden-patents-340b/?utm_campaign=rss
Etiketler: